Canaccord Genuity is bullish on Tesla Inc‘s (NASDAQ:TSLA) long-term prospects while simultaneously being cautious of a near-term growth slowdown. What Happened: “We think Tesla is Apple on steroids as it focuses on manufacturing and a higher level of vertical integration,” Canaccord said in a note. The firm continues to maintain a ‘buy’ rating on the stock with a price target of $267. The company believes the EV giant to be the ‘sustainability behemoth’ with its vehicle autonomy goals and the stainless steel Cybertruck. While the stock had a strong 2023 despite reduced earnings estimates, Cana…